References
- Pollak C, Hagemeijer A. Abnormalities of the short arm of chromosome 9 with partial loss of material in hematological disorders. Leukemia. 1987;1:541–548.
- Shah D, Bond M, Kilby AM, et al. Widespread bone disease in acute myeloid leukaemia. Leuk Lymphoma. 2001;42:1309–1314.
- Silva MLM, Ornellas de Souza MH, Ribeiro RC, et al. Cytogenetic analysis of 100 consecutive newly diagnosed cases of acute lymphoblastic leukemia in Rio de Janeiro. Cancer Genet Cytogenet. 2002;137:185–190.
- Barjesteh van Waalwijk van Doorn-Khosrovani S, Erpelinck C, van Putten WLJ, et al. High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients. Blood. 2003;101:837–845.
- Dicker F, Haferlach C, Kern W, et al. Trisomy 13 is strongly associated with AML1/RUNX1 mutations and increased FLT3 expression in acute myeloid leukemia. Blood. 2007;110:1308–1316.
- Tempescul A, Guillerm G, Douet-Guilbert N, et al. Translocation (10;17)(p15;q21) is a recurrent anomaly in acute myeloblastic leukemia. Cancer Genet Cytogenet. 2007;172:74–76.
- De Braekeleer E, Auffret R, Douet-Guilbert N, et al. Recurrent translocation (10;17)(p15;q21) in acute poorly differentiated myeloid leukemia likely results in ZMYND11-MBTD1 fusion. Leuk Lymphoma. 2014;55:1189–1190.
- de Rooij JDE, van den Heuvel-Eibrink MM, Kollen WJW, et al. Recurrent translocation t(10;17)(p15;q21) in minimally differentiated acute myeloid leukemia results in ZMYND11/MBTD1 fusion. Genes Chromosomes Cancer. 2016;55:237–241.
- Huret JL. ZMYND11 (zinc finger MYND-type containing 11). Atlas Genet Cytogenet Oncol Haematol. Dec 2017. Available from: http://atlasgeneticsoncology.org/Genes/GC_ZMYND11.html
- Wen H, Li Y, Xi Y, et al. ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour suppression. Nature. 2014;508:263–268.
- Eryilmaz J, Pan P, Amaya MF, et al. Structural studies of a four-MBT repeat protein MBTD1. PLoS One. 2009;4:e7274.
- Dewaele B, Przybyl J, Quattrone A, et al. Identification of a novel, recurrent MBTD1-CXorf67 fusion in low-grade endometrial stromal sarcoma. Int J Cancer. 2014;134:1112–1122.
- Suzuki R, Yamamoto K, Seto M, et al. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity. Blood. 1997;90:2417–2428.
- Abdelhaleem M, Shago M, Sayeh E, et al. Childhood myeloid/natural killer precursor acute leukemia with novel chromosomal aberrations der(5)t(4;5)(q31;q31.3) and t(14;17)(q32;q23). Cancer Genet Cytogenet. 2007;178:141–143.
- Dinçol G, Palandüz Ş, Nalçacı M, et al. Myeloid/natural killer cell precursor acute leukemia with tetraploidy. Cancer Genet Cytogenet. 2005;163:156–159.